The company’s return profile remains strong, with ROE/ROCE at 25–26%/21–23% over FY21–24E. We maintain 'buy'. As highlighted in its annual report, the company is embarking on a major diversification journey, which we discussed with the management today.
from The Financial Express https://ift.tt/3tZrObh
https://ift.tt/eA8V8J Motilal Oswal
from The Financial Express https://ift.tt/3tZrObh
https://ift.tt/eA8V8J Motilal Oswal
Comments
Post a Comment